ClinicalTrials.gg
Not yet recruitingNCT07944521ANUBIUpdated Nov 18, 2026

Avoidable Deaths After Non Traumatic Emergency General Surgery Registry

An observational study in Non-Traumatic Emergency General Surgery Conditions, Acute Abdomen and Intra-Abdominal Infection, sponsored by World Society of Emergency Surgery. Not yet recruiting. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by World Society of Emergency Surgery · Observational

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
400
Sex
All
01

Study summary

Background: Non traumatic Emergency general surgery disease are responsible for significant morbidity and mortality. In clinical practice a good number of deaths could probably be avoided. This may be related to delayed clinical decisions, imaging, or laboratory diagnostic inaccuracy. Objective: The ANUBI Registry aims to analyze avoidable deaths in non traumatic emergency general diseases evaluating all risk factors. Methods: ANUBI is a multicenter, prospective, registry carried out across multiple continents. Adult patients admitted and died for non traumatic emergency general surgery disease will be included. Data collection will be focused on all medical, surgical, radiologic, laboratory informations. Results The primary outcome is the incidence of avoidable death. Secondary outcomes include all possible factors affecting related decision-making and preventability of death. Conclusions: ANUBI aims globally assess preventable deaths in non traumatic emergency general surgery diseases analyzing potentially practice changing factors to patients' outcomes.

Read the detailed description

Urgent and emergent surgical interventions are complicated with high morbidity and mortality. Emergency surgery is one of the most challenging areas of surgery. Patients requiring acute care surgery interventions have advanced disease in the majority of cases, physiological derangement, and limited time for diagnosis and optimization. Thus morbidity and mortality rates are higher than elective surgery in spite of modern improvements in surgery, anesthesia and critical care. Many factors contribute to the poor outcomes in these patients: limited access to health care, delayed presentation, underestimation, and delayed diagnosis. Emergency surgical patients often present with sepsis, bleedings, shock, metabolic acidosis, coagulopathy, or hypothermia, which undermine the physiological reserve increasing morbidity and mortality. At the time of hospital admission this physiological derangement is already established which worsens overtime. All this is particularly amplified for special populations such as frails and/or elderly; there are even more vulnerable populations such as immunocompromised, pregnant, heart failure, respiratory insufficiency and anticoagulated patients. Acute care surgery procedures may have major complications, prolonged intensive care stay, and poor outcomes.

The urgent nature of these interventions limits opportunities for preoperative optimization and shared decision-making. Organizational factors play an important role: out-of-hours activity, lack of senior surgical expertise, lack of senior anesthesiology expertise, interventional radiology unavailability, lack of senior endoscopic expertise and intensive care resources paucity. All these factors are responsible of delayed/ineffective source control and poor perioperative care. Variability in protocols and experience are other significant contributors with different results among centers. Normally outcomes evaluation in emergency surgery is focused on mortality and morbidity, (M and M Meetings) without analyzing prevention and avoidability. There is a good evidence showing substantially that adverse outcomes are influenced by clinical, organizational, and decision-making factors. So it is important to identify these factors with accurate observational registries aiming to reduce preventable morbidity and mortality. In this setting, an accurate multicenter investigation on avoidable mortality in emergency general surgery is needed to improve perioperative strategies, and optimize patient safety. The ANUBI registry is the first multicenter registry that prospectively investigates fatal events following urgent surgical disease to analyze their potential avoidability using a structured evaluation.

Rationale

Emergency general surgery (non trauma) is a critical discipline in medicine responsible for a significant morbidity and mortality. In spite of improvements in surgery and perioperative care, mortality and morbidity rates remain higher compared with elective surgery. In most cases these adverse events occur in fragile patients caused by delayed diagnosis and/or inappropriate therapy. A hot issue for example is the identification of subjects who need second look after peritonitis or bowel ischemia. The decision making is based on clinical evaluation, imaging, laboratory tests which have low accuracy. The critical dilemma is always the same: delayed redo surgery and multi organ failure or unnecessary relaparotomy with additional morbidity and mortality. So, a significant number of deaths are avoidable with improvements in diagnosis and source control. We do not know the real incidence and risk factors of avoidable or probably avoidable deaths. There is no registry to identify and analyze these adverse events worldwide. The ANUBI Registry is designed to give specific answers on avoidable fatal events, focusing on possible determinants and quantifying the true incidence.

Moreover biomarkers (e.g. procalcitonin), imaging, and clinical scores will be analyzed for the influence on decision making.

A fundamental innovation of the ANUBI Registry is its global, prospective, observational approach across five continents. This analysis is going to investigate different clinical practices, resources, and decision-making strategies. It is aligned with precision surgery, tailored approach and value-based care. Avoiding death factors is a key strategy to reduce mortality and morbidity. This registry aims to transform reactive emergency surgery into an outcome-oriented emergency surgery.

02

Conditions studied

  • Non-Traumatic Emergency General Surgery Conditions
  • Acute Abdomen
  • Intra-Abdominal Infection
  • Acute Mesenteric Ischemia
  • Intestinal Obstruction
  • Gastrointestinal Perforation
  • Acute Gastrointestinal Hemorrhage
  • Sepsis

Keywords

  • Emergency General Surgery
  • Non-Traumatic Surgical Emergencies
  • Avoidable Death
  • Preventable Mortality
  • Patient Safety
  • Failure to Rescue
  • Clinical Decision-Making
  • Source Control
  • Quality Improvement
  • Mortality Adjudication
03

In context

Abdomen, Acute

66 studies on the registry are indexed under Abdomen, Acute; 15 are open to participants now.

This study's planned enrollment of 400 is above the median of 250 across 37 observational studies indexed under Abdomen, Acute.

Browse Abdomen, Acute studies →

Lead sponsor

World Society of Emergency Surgery is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of consecutive adult patients (aged ≥18 years) admitted to participating hospitals with acute non-traumatic emergency general surgical conditions who undergo urgent or emergency surgical, therapeutic endoscopic, or interventional radiological procedures during the index hospitalization and die within 180 days of the index admission.

Patients will be identified across participating centers in different countries and healthcare settings, including emergency departments, surgical wards, operating rooms, and intensive care units.

Eligible cases will include deaths occurring during hospitalization, after discharge, or following transfer to another healthcare institution.

All eligible fatal events will be included regardless of their potential avoidability. Each case will undergo independent expert adjudication to assess the potential contribution of clinical, diagnostic, therapeutic, and organizational factors to death.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients aged 18 years or older at the time of index hospital admission.
  • Emergency hospital admission for an acute non-traumatic surgical condition requiring urgent or emergency management.
  • Patients undergoing at least one non-elective surgical, therapeutic endoscopic, or interventional radiological procedure during the same hospital admission to treat the acute condition or its related complications.
  • Qualifying procedures may be performed after initial resuscitation, physiological stabilization, or a period of non-operative management, including interventions performed more than 72 hours after hospital admission.
  • Death from any cause occurring within 180 days of the index hospital admission, including in-hospital death, death after discharge, or death following transfer to another healthcare institution.

Exclusion criteria

Exclusion Criteria:

  • Patients younger than 18 years.
  • Patients admitted for planned elective surgical procedures.
  • Patients undergoing exclusively palliative surgical, endoscopic, or interventional radiological procedures.
  • Patients managed exclusively through a comfort-only care pathway.
  • Patients who do not undergo a qualifying surgical, therapeutic endoscopic, or interventional radiological procedure during the index hospital admission.
  • Patients who do not die within 180 days of the index hospital admission.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
400 participants (estimated)
Target follow-up
180 Days
Patient registry
Yes

Groups and cohorts

  • Fatal Events Following Non-Traumatic Emergency General Surgery

    Adult patients (≥18 years) admitted for acute non-traumatic emergency general surgical conditions who undergo at least one non-elective surgical, therapeutic endoscopic, or interventional radiological procedure during the index hospitalization and die from any cause within 180 days of the index admission. Qualifying procedures may be performed after initial resuscitation, physiological stabilization, or a period of non-operative management. All eligible fatal events will be included regardless of their potential avoidability. Deaths will undergo independent expert adjudication to classify them as definitely avoidable, probably avoidable, or not avoidable. This is a non-interventional observational registry. All diagnostic and therapeutic decisions will follow routine clinical practice, without any study-assigned intervention.

06

What researchers measure

Primary outcomes

  1. Proportion of Avoidable and Probably Avoidable Deaths Following Non-Traumatic Emergency General Surgery

    The primary outcome is the proportion of deaths classified as definitely avoidable or probably avoidable among all registered deaths following non-traumatic emergency general surgery conditions. Avoidability will be determined through blinded independent expert review using predefined clinical, diagnostic, therapeutic, and organizational criteria. The primary measure will be calculated as the number of definitely or probably avoidable deaths divided by the total number of registered deaths, multiplied by 100.

    Time frame: From index hospital admission to death, up to 180 days

Secondary outcomes

  1. Timing and Distribution of Deaths

    Number and proportion of registered deaths occurring during the index hospitalization, within 30 days of index admission, and between days 31 and 180 after index admission. Time from admission to death will also be described.

    Time frame: From index hospital admission to death, up to 180 days

  2. Major Surgical Complications

    Number and proportion of registered patients with major surgical complications, including anastomotic leak, intra-abdominal abscess, postoperative bleeding, sepsis, and septic shock. Complications will be characterized using the Clavien-Dindo classification and the Comprehensive Complication Index, as applicable.

    Time frame: From index admission to death, up to 180 days

  3. Major Medical Complications and Organ Failure

    Number and proportion of registered patients experiencing respiratory failure requiring ventilatory support, acute kidney injury requiring renal replacement therapy, ischemic events, infections, or other organ failures.

    Time frame: From index admission to death, up to 180 days

  4. Unplanned Surgical, Endoscopic, and Radiological Reinterventions

    Number and proportion of registered patients undergoing unplanned reinterventions, including relaparotomy, relaparoscopy, interventional radiology, and therapeutic endoscopy. Reintervention types, indications, timing, and procedural findings will be described.

    Time frame: From index admission to death, up to 180 days

  5. Inadequate Source Control

    Number and proportion of registered patients with documented inadequate control of infection, bleeding, obstruction, or another acute surgical condition. The need for an additional surgical, endoscopic, or radiological intervention to achieve source control will be recorded.

    Time frame: From index admission to death, up to 180 days

  6. Diagnostic and Therapeutic Delays

    Time intervals from hospital presentation to diagnosis, from hospital presentation to treatment decision, and from hospital presentation to initiation of definitive treatment or source control. Documented delays in imaging, transfer, treatment escalation, intensive care admission, and reintervention will also be assessed.

    Time frame: From index admission to death, up to 180 days

  7. Critical Care Utilization

    Number and proportion of registered patients requiring intensive or high-dependency care, unplanned ICU admission or readmission, unplanned intubation, vasopressor support, mechanical ventilation, or renal replacement therapy. Duration of organ support and ICU stay will be described.

    Time frame: From index admission to death, up to 180 days

  8. Failure to Rescue Following Major Complications

    Number and proportion of registered deaths preceded by a documented major postoperative complication, with characterization of failure to recognize, escalate, or adequately manage the complication. This case-only assessment will not estimate the population-level failure-to-rescue rate.

    Time frame: From index admission to death, up to 180 days

  9. Clinical and Organizational Factors Contributing to Avoidable Death

    Number and proportion of adjudicated cases in which independent reviewers identify diagnostic failures, therapeutic or technical failures, inadequate postoperative surveillance, communication failures, staffing limitations, resource constraints, or organizational delays as contributing factors to potentially avoidable death.

    Time frame: At independent adjudication of deaths occurring within 180 days of index admission

  10. Adherence to Recommended Perioperative Care

    Number and proportion of eligible registered cases with documented adherence to prespecified care processes, including timely antimicrobial prophylaxis or treatment, lactate and procalcitonin measurements, microbiological testing, thromboprophylaxis, respiratory support, and other relevant perioperative management measures.

    Time frame: Perioperative/Periprocedural

  11. Availability of Specialist Expertise and Emergency Care Resources

    Frequency of documented availability and involvement of senior surgical staff and relevant specialist teams, emergency operating rooms, intensive or high-dependency care, interventional radiology, and interventional endoscopy. Organizational characteristics will be evaluated in relation to death avoidability classification.

    Time frame: up to 180 days

  12. Total Hospital Length of Hospital (days)

    Total duration of hospitalization during the index admission, calculated from hospital admission to discharge or in-hospital death using hospital medical records. The outcome will be expressed in days.

    Time frame: From index hospital admission to discharge or in-hospital death (up to 180 days)

  13. Clinical Factors Associated With Death Avoidability

    Associations between expert-adjudicated death avoidability and prespecified patient, clinical, physiological, treatment-related, and organizational variables, including age, frailty, comorbidity burden, septic shock, lactate, procalcitonin, treatment delays, consultant involvement, and hospital resources.

    Time frame: At independent adjudication of deaths occurring within 180 days of index admission

  14. Inter-Reviewer Agreement in Death Avoidability Assessment

    Agreement among three independent expert reviewers regarding avoidability classification, assessed using percentage agreement and an appropriate kappa statistic.

    Time frame: At independent adjudication of deaths occurring within 180 days of index admission

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2027; primary completion for Jun 2029, 24 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 28, 2026
First posted
Nov 18, 2026
StartEst.
Jun 1, 2027
Primary completionEst.
Jun 1, 2029
CompletionEst.
Jun 1, 2035
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07944521
Lead sponsor
World Society of Emergency Surgery
Responsible party
FAUSTO CATENA (Professor of Surgery, World Society of Emergency Surgery) — Principal investigator
First posted
Nov 18, 2026
Start date
Jun 1, 2027 (estimated)
Primary completion
Jun 1, 2029 (estimated)
Completion
Jun 1, 2035 (estimated)
Last update
Nov 18, 2026

Study contacts

Fausto Catena, Professor
Contact
faustocatena@gmail.com
+393388560294
Belinda De Simone, Dr
Contact
desimone.belinda@gmail.com
+33665787872
Fausto Catena, Professor
study chair · World Society of Emergency Surgery-Institute for Research in Emergency General Surgery (WSES-IREGS)
Belinda De Simone, MD
principal investigator · World Society of Emergency Surgery-Institute for Research in Emergency General Surgery (WSES-IREGS)
Fikri Abu-Zidan, Professor
principal investigator · UAE University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion